Novel mechanisms and functions of complement (original) (raw)

• Ricklin, D., Hajishengallis, G., Yang, K. & Lambris, J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11, 785–797 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Arbore, G., Kemper, C. & Kolev, M. Intracellular complement - the complosome - in immune cell regulation. Mol. Immunol. 89, 2–9 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Ricklin, D., Reis, E.S. & Lambris, J.D. Complement in disease: a defence system turning offensive. Nat. Rev. Nephrol. 12, 383–401 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Elmlund, D., Le, S.N. & Elmlund, H. High-resolution cryo-EM: the nuts and bolts. Curr. Opin. Struct. Biol. 46, 1–6 (2017).
  Article CAS PubMed Google Scholar
• Ricklin, D., Reis, E.S., Mastellos, D.C., Gros, P. & Lambris, J.D. Complement component C3 - The “Swiss Army Knife” of innate immunity and host defense. Immunol. Rev. 274, 33–58 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Schatz-Jakobsen, J.A., Pedersen, D.V. & Andersen, G.R. Structural insight into proteolytic activation and regulation of the complement system. Immunol. Rev. 274, 59–73 (2016).
  Article CAS PubMed Google Scholar
• Liszewski, M.K., Elvington, M., Kulkarni, H.S. & Atkinson, J.P. Complement's hidden arsenal: new insights and novel functions inside the cell. Mol. Immunol. 84, 2–9 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Hajishengallis, G. & Lambris, J.D. More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation. Immunol. Rev. 274, 233–244 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Hovingh, E.S., van den Broek, B. & Jongerius, I. Hijacking complement regulatory proteins for bacterial immune evasion. Front. Microbiol. 7, 2004 (2016).
  Article PubMed PubMed Central Google Scholar
• Dempsey, P.W., Allison, M.E., Akkaraju, S., Goodnow, C.C. & Fearon, D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271, 348–350 (1996).
  Article CAS PubMed Google Scholar
• Kaya, Z. et al. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat. Immunol. 2, 739–745 (2001).
  Article CAS PubMed Google Scholar
• Strainic, M.G. et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28, 425–435 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Liszewski, M.K. et al. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity 39, 1143–1157 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Arbore, G. et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells. Science 352, aad1210 (2016). This study shows that complement and the NLRP3 inflammasome, two systems traditionally associated with innate immunity, can also operate within T cells, forming a C5aR1–NLRP3 axis that guides the differentiation of CD4+ T cells into the T H 1 subset.
  Article CAS PubMed PubMed Central Google Scholar
• Lambris, J.D., Dobson, N.J. & Ross, G.D. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin. J. Exp. Med. 152, 1625–1644 (1980).
  Article CAS PubMed Google Scholar
• Sundsmo, J.S. The leukocyte complement system. Fed. Proc. 41, 3094–3098 (1982). References 15 and 16 involve old but pioneering studies describing the synthesis of complement components and regulators by human lymphocytes, whose intracellular complement system has only now begun to be functionally appreciated.
  CAS PubMed Google Scholar
• Freeley, S., Kemper, C. & Le Friec, G. The “ins and outs” of complement-driven immune responses. Immunol. Rev. 274, 16–32 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Elvington, M., Liszewski, M.K., Bertram, P., Kulkarni, H.S. & Atkinson, J.P.A. A C3(H20) recycling pathway is a component of the intracellular complement system. J. Clin. Invest. 127, 970–981 (2017). This investigation identifies a C3-recycling pathway between the extracellular compartment and intracellular compartment and thus identifies a previously unknown source of the intracellular complement components.
  Article PubMed PubMed Central Google Scholar
• Kolev, M. & Kemper, C. Keeping it all going-complement meets metabolism. Front. Immunol. 8, 1 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Kolev, M. et al. Complement regulates nutrient influx and metabolic reprogramming during Th1 cell responses. Immunity 42, 1033–1047 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Cardone, J. et al. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 11, 862–871 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Acosta-Rodriguez, E.V., Napolitani, G., Lanzavecchia, A. & Sallusto, F. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942–949 (2007).
  CAS PubMed Google Scholar
• Khameneh, H.J. et al. C5a regulates IL-1β production and leukocyte recruitment in a murine model of monosodium urate crystal-induced peritonitis. Front. Pharmacol. 8, 10 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Asgari, E. et al. C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. Blood 122, 3473–3481 (2013).
  Article CAS PubMed Google Scholar
• Triantafilou, K., Hughes, T.R., Triantafilou, M. & Morgan, B.P. The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. J. Cell Sci. 126, 2903–2913 (2013).
  Article CAS PubMed Google Scholar
• Laudisi, F. et al. Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1β release. J. Immunol. 191, 1006–1010 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Gurcel, L., Abrami, L., Girardin, S., Tschopp, J. & van der Goot, F.G. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126, 1135–1145 (2006).
  Article CAS PubMed Google Scholar
• Benoit, M.E., Clarke, E.V., Morgado, P., Fraser, D.A. & Tenner, A.J. Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells. J. Immunol. 188, 5682–5693 (2012).
  Article CAS PubMed Google Scholar
• Levy, M., Kolodziejczyk, A.A., Thaiss, C.A. & Elinav, E. Dysbiosis and the immune system. Nat. Rev. Immunol. 17, 219–232 (2017).
  Article CAS PubMed Google Scholar
• Hajishengallis, G., Abe, T., Maekawa, T., Hajishengallis, E. & Lambris, J.D. Role of complement in host-microbe homeostasis of the periodontium. Semin. Immunol. 25, 65–72 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Hajishengallis, G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol. 35, 3–11 (2014).
  Article CAS PubMed Google Scholar
• Hasegawa, M. et al. Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage. Immunity 41, 620–632 (2014). This study integrates IL-22-mediated immunity and complement by showing that the regulation of C3 by IL-22 leads to protection of the host from pathobionts that enter the systemic circulation.
  Article CAS PubMed PubMed Central Google Scholar
• Chehoud, C. et al. Complement modulates the cutaneous microbiome and inflammatory milieu. Proc. Natl. Acad. Sci. USA 110, 15061–15066 (2013).
  Article PubMed PubMed Central Google Scholar
• Wang, H.-B., Ricklin, D. & Lambris, J.D. Complement activation fragment C4a, a novel untethered agonist, mediates effector functions by binding to PAR1 and PAR4. Proc. Natl. Acad. Sci. USA (in the press).
• Ekdahl, K.N. et al. Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross-talk act as a linchpin in the events leading to thromboinflammation. Immunol. Rev. 274, 245–269 (2016).
  Article CAS PubMed Google Scholar
• Riewald, M., Petrovan, R.J., Donner, A., Mueller, B.M. & Ruf, W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296, 1880–1882 (2002).
  Article CAS PubMed Google Scholar
• Schonthaler, H.B. et al. S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. Immunity 39, 1171–1181 (2013).
  Article CAS PubMed Google Scholar
• Rafail, S. et al. Complement deficiency promotes cutaneous wound healing in mice. J. Immunol. 194, 1285–1291 (2015).
  Article CAS PubMed Google Scholar
• Winter, S.E. & Bäumler, A.J. Dysbiosis in the inflamed intestine: chance favors the prepared microbe. Gut Microbes 5, 71–73 (2014).
  Article PubMed PubMed Central Google Scholar
• Hajishengallis, G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol. 15, 30–44 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Maekawa, T. et al. Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis. Cell Host Microbe 15, 768–778 (2014). This study shows that dysbiotic bacteria manipulate complement–TLR crosstalk to inhibit bactericidal mechanisms while promoting a nutritionally favorable inflammatory response; the uncoupling of immune bacterial clearance from inflammation perpetuates dysbiosis and inflammatory disease.
  Article CAS PubMed PubMed Central Google Scholar
• Hajishengallis, G. et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10, 497–506 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Tam, J.C., Bidgood, S.R., McEwan, W.A. & James, L.C. Intracellular sensing of complement C3 activates cell autonomous immunity. Science 345, 1256070 (2014). This study reveals previously unknown intracellular antimicrobial functions of extracellularly activated complement: after escaping from phagosomes, C3-opsonized nonenveloped viruses and bacteria can be sensed in the cytosol in a C3-dependent manner, which leads to signaling via the innate immune system and proteasome-mediated viral degradation.
  Article CAS PubMed PubMed Central Google Scholar
• Helmy, K.Y. et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124, 915–927 (2006).
  Article CAS PubMed Google Scholar
• Zeng, Z. et al. CRIg functions as a macrophage pattern recognition receptor to directly bind and capture blood-borne gram-positive bacteria. Cell Host Microbe 20, 99–106 (2016).
  Article CAS PubMed Google Scholar
• Kim, K.H. et al. Extracellular stimulation of VSIG4/complement receptor Ig suppresses intracellular bacterial infection by inducing autophagy. Autophagy 12, 1647–1659 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Mosser, D.M. & Edelson, P.J. The third component of complement (C3) is responsible for the intracellular survival of Leishmania major. Nature 327, 329–331 (1987).
  Article PubMed Google Scholar
• Dai, S., Rajaram, M.V., Curry, H.M., Leander, R. & Schlesinger, L.S. Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis. PLoS Pathog. 9, e1003114 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Lambris, J.D., Ricklin, D. & Geisbrecht, B.V. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6, 132–142 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Bennett, K.M., Rooijakkers, S.H.M. & Gorham, R.D. Jr. Let's tie the knot: marriage of complement and adaptive immunity in pathogen evasion, for better or worse. Front. Microbiol. 8, 89 (2017).
  Article PubMed PubMed Central Google Scholar
• Ricklin, D. & Lambris, J.D. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J. Immunol. 190, 3831–3838 (2013).
  Article CAS PubMed Google Scholar
• Shaw, A.C., Goldstein, D.R. & Montgomery, R.R. Age-dependent dysregulation of innate immunity. Nat. Rev. Immunol. 13, 875–887 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• van Lookeren Campagne, M., Strauss, E.C. & Yaspan, B.L. Age-related macular degeneration: complement in action. Immunobiology 221, 733–739 (2016).
  Article CAS PubMed Google Scholar
• Brennan, F.H., Lee, J.D., Ruitenberg, M.J. & Woodruff, T.M. Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions. Semin. Immunol. 28, 292–308 (2016).
  Article CAS PubMed Google Scholar
• Thurman, J.M. Complement in kidney disease: core curriculum 2015. Am. J. Kidney Dis. 65, 156–168 (2015).
  Article PubMed Google Scholar
• Stephan, A.H., Barres, B.A. & Stevens, B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci. 35, 369–389 (2012).
  Article CAS PubMed Google Scholar
• Liddelow, S.A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481–487 (2017). This paper provides mechanistic evidence of pathogenic crosstalk between complement and reactive microglia in the central nervous system. It reveals a key role of complement in the induction of A1 astrocytes, which mediate neurotoxic effects in various neurodegenerative diseases.
  Article CAS PubMed PubMed Central Google Scholar
• Hawksworth, O.A., Coulthard, L.G. & Woodruff, T.M. Complement in the fundamental processes of the cell. Mol. Immunol. 84, 17–25 (2017).
  Article CAS PubMed Google Scholar
• Stevens, B. et al. The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164–1178 (2007). This work identifies C1q and C3 as key contributors to synaptic refinement and neuronal connectivity in the central nervous system. It is the first report to link complement-triggered pathways to the regulation of developmental synaptic pruning, while prompting the question whether this phenomenon is recapitulated in neurological diseases associated with aberrant synapse loss.
  Article CAS PubMed Google Scholar
• Schafer, D.P. et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74, 691–705 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Bialas, A.R. & Stevens, B. TGF-β signaling regulates neuronal C1q expression and developmental synaptic refinement. Nat. Neurosci. 16, 1773–1782 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Howell, G.R. et al. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J. Clin. Invest. 121, 1429–1444 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Shi, Q. et al. Complement C3-deficient mice fail to display age-related hippocampal decline. J. Neurosci. 35, 13029–13042 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Whalley, K. Neurodegenerative disease: complement mediates pathological pruning. Nat. Rev. Neurosci. 17, 336 (2016).
  Article CAS PubMed Google Scholar
• Vasek, M.J. et al. A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature 534, 538–543 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Wyatt, S.K., Witt, T., Barbaro, N.M., Cohen-Gadol, A.A. & Brewster, A.L. Enhanced classical complement pathway activation and altered phagocytosis signaling molecules in human epilepsy. Exp. Neurol. 295, 184–193 (2017).
  Article CAS PubMed Google Scholar
• Heppner, F.L., Ransohoff, R.M. & Becher, B. Immune attack: the role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 16, 358–372 (2015).
  Article CAS PubMed Google Scholar
• Veerhuis, R., Nielsen, H.M. & Tenner, A.J. Complement in the brain. Mol. Immunol. 48, 1592–1603 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Ager, R.R. et al. Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease. J. Neurochem. 113, 389–401 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Fonseca, M.I. et al. Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease. J. Immunol. 183, 1375–1383 (2009).
  Article CAS PubMed Google Scholar
• Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712–716 (2016). This paper establishes a link between early neurodenerative pathways in Alzheimer′s disease and aberrant reactivation of complement-mediated synaptic pruning programs in the CNS. It supports the notion that early synapse loss is a hallmark of cognitive decline in Alzheimer′s disease that actually precedes the appearance of pathogenic amyloid plaques.
  Article CAS PubMed PubMed Central Google Scholar
• Shi, Q. et al. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice. Sci. Transl. Med. 9, eaaf6295 (2017).
  Article PubMed PubMed Central Google Scholar
• Liu, H. et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317, 803–806 (2007).
  Article CAS PubMed Google Scholar
• Naito, A.T. et al. Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. Cell 149, 1298–1313 (2012). This is the first report to link C1q to aging-related processes, indicative of wider implications of a role for complement in subverted tissue homeostasis (impaired tissue repair) during ageing.
  Article CAS PubMed PubMed Central Google Scholar
• Clevers, H. Wnt/β-catenin signaling in development and disease. Cell 127, 469–480 (2006).
  Article CAS PubMed Google Scholar
• Sumida, T. et al. Complement C1q-induced activation of β-catenin signalling causes hypertensive arterial remodelling. Nat. Commun. 6, 6241 (2015).
  Article CAS PubMed Google Scholar
• Castellano, G. et al. Complement modulation of anti-aging factor klotho in ischemia/reperfusion injury and delayed graft function. Am. J. Transplant. 16, 325–333 (2016).
  Article CAS PubMed Google Scholar
• Hageman, G.S. et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 102, 7227–7232 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Haines, J.L. et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419–421 (2005).
  Article CAS PubMed Google Scholar
• Calippe, B. et al. Complement factor H inhibits CD47-mediated resolution of inflammation. Immunity 46, 261–272 (2017). This study offers a new perspective on the increasingly complex pathogenic role of complement in AMD, ascribing to the AMD-predisposing FH variant H402 a novel role in perpetuating subretinal inflammation through impaired phagocyte clearance from the subretinal space.
  Article CAS PubMed Google Scholar
• Wang, Q. et al. Identification of a central role for complement in osteoarthritis. Nat. Med. 17, 1674–1679 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Maekawa, T. et al. Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis. J. Immunol. 192, 6020–6027 (2014).
  Article CAS PubMed Google Scholar
• Maekawa, T. et al. Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3. J. Clin. Periodontol. 43, 238–249 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Pandey, M.K. et al. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease. Nature 543, 108–112 (2017).
  Article CAS PubMed Google Scholar
• Trinchieri, G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu. Rev. Immunol. 30, 677–706 (2012).
  Article CAS PubMed Google Scholar
• Balkwill, F.R. & Mantovani, A. Cancer-related inflammation: common themes and therapeutic opportunities. Semin. Cancer Biol. 22, 33–40 (2012).
  Article CAS PubMed Google Scholar
• Hanahan, D. & Weinberg, R.A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
  Article CAS PubMed Google Scholar
• Hajishengallis, G. et al. Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application. Semin. Immunol. 28, 285–291 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Kemper, C. & Köhl, J. Novel roles for complement receptors in T cell regulation and beyond. Mol. Immunol. 56, 181–190 (2013).
  Article CAS PubMed Google Scholar
• Reis, E.S., Mastellos, D.C., Ricklin, D., Mantovani, A. & Lambris, J.D. Complement in cancer: untangling an intricate relationship. Nat. Rev. Immunol. (in the press).
• Hsieh, C.C. et al. The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood 121, 1760–1768 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Markiewski, M.M. et al. Modulation of the antitumor immune response by complement. Nat. Immunol. 9, 1225–1235 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Corrales, L. et al. Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression. J. Immunol. 189, 4674–4683 (2012).
  Article CAS PubMed Google Scholar
• Doerner, S.K. et al. High-fat diet-induced complement activation mediates intestinal inflammation and neoplasia, independent of obesity. Mol. Cancer Res. 14, 953–965 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Guglietta, S. et al. Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis. Nat. Commun. 7, 11037 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Nabizadeh, J.A. et al. The complement C3a receptor contributes to melanoma tumorigenesis by inhibiting neutrophil and CD4+ T cell responses. J. Immunol. 196, 4783–4792 (2016).
  Article CAS PubMed Google Scholar
• Ning, C. et al. Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axis. Mucosal Immunol. 8, 1275–1284 (2015).
  Article CAS PubMed Google Scholar
• Vadrevu, S.K. et al. Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche. Cancer Res. 74, 3454–3465 (2014).
  Article CAS PubMed Google Scholar
• Bonavita, E. et al. PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer. Cell 160, 700–714 (2015). This study identifies a previously unknown role for PTX3 as suppressor of tumorigenesis through the regulation of complement and inflammatory responses.
  Article CAS PubMed Google Scholar
• Ajona, D. et al. A combined PD-1/C5a Blockade synergistically protects against lung cancer growth and metastasis. Cancer Discov. 7, 694–703 (2017).
  Article CAS PubMed Google Scholar
• Bulla, R. et al. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nat. Commun. 7, 10346 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Ajona, D. et al. Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer. J. Natl. Cancer Inst. 105, 1385–1393 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Nunez-Cruz, S. et al. Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization. Neoplasia 14, 994–1004 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kaida, T. et al. C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA. Oncotarget 7, 84798–84809 (2016).
  Article PubMed PubMed Central Google Scholar
• Abdelbaset-Ismail, A. et al. Activation of the complement cascade enhances motility of leukemic cells by downregulating expression of HO-1. Leukemia 31, 446–458 (2017).
  Article CAS PubMed Google Scholar
• Han, X., Zha, H., Yang, F., Guo, B. & Zhu, B. Tumor-derived tissue factor aberrantly activates complement and facilitates lung tumor progression via recruitment of myeloid-derived suppressor cells. Int. J. Mol. Sci. 18, 22 10.3390/ijms18010022 (2017).
  Article CAS PubMed Central Google Scholar
• Boire, A. et al. Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis. Cell 168, 1101–1113 e13 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Cho, M.S. et al. Complement component 3 is regulated by TWIST1 and mediates epithelial-mesenchymal transition. j. immunol. 196, 1412–1418 (2016).
  Article CAS PubMed Google Scholar
• Towner, L.D., Wheat, R.A., Hughes, T.R. & Morgan, B.P. Complement membrane attack and tumorigenesis: a systems biology approach. J. Biol. Chem. 291, 14927–14938 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Y. et al. Autocrine complement inhibits IL10-dependent T-cell-mediated antitumor immunity to promote tumor progression. Cancer Discov. 6, 1022–1035 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Surace, L. et al. Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response. Immunity 42, 767–777 (2015).
  Article CAS PubMed Google Scholar
• Taylor, R.P. & Lindorfer, M.A. Cytotoxic mechanisms of immunotherapy: harnessing complement in the action of anti-tumor monoclonal antibodies. Semin. Immunol. 28, 309–316 (2016).
  Article CAS PubMed Google Scholar
• Gunn, L. et al. Opposing roles for complement component C5a in tumor progression and the tumor microenvironment. J. Immunol. 189, 2985–2994 (2012).
  Article CAS PubMed Google Scholar
• Facciabene, A. et al. Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy. OncoImmunology 6, e1326442 (2017).
  Article PubMed PubMed Central Google Scholar
• Diebolder, C.A. et al. Complement is activated by IgG hexamers assembled at the cell surface. Science 343, 1260–1263 (2014). This seminal study uses a panel of structural and biochemical methods to provide an unprecedented molecular insight into initiation of the classical pathway by IgG hexamers, with implications for the understanding of complement activation and the design of therapeutic antibodies.
  Article CAS PubMed PubMed Central Google Scholar
• de Jong, R.N. et al. A novel platform for the potentiation of therapeutic antibodies based on antigen-dependent formation of IgG hexamers at the cell surface. PLoS Biol. 14, e1002344 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Cook, E.M. et al. Antibodies that efficiently form hexamers upon antigen binding can induce complement-dependent cytotoxicity under complement-limiting conditions. J. Immunol. 197, 1762–1775 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Forneris, F. et al. Structures of C3b in complex with factors B and D give insight into complement convertase formation. Science 330, 1816–1820 (2010). By describing the tiered interaction among C3b, FB and FD, this elegant study builds an important base for explaining the intrinsic and extrinsic control of complement activation and amplification as mediated by the alternative-pathway C3 convertase.
  Article CAS PubMed PubMed Central Google Scholar
• Katschke, K.J. Jr. et al. Inhibiting alternative pathway complement activation by targeting the factor D exosite. J. Biol. Chem. 287, 12886–12892 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Mastellos, D.C. et al. Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention. Eur. J. Clin. Invest. 45, 423–440 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Forneris, F. et al. Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode. EMBO J. 35, 1133–1149 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Roversi, P. et al. Structural basis for complement factor I control and its disease-associated sequence polymorphisms. Proc. Natl. Acad. Sci. USA 108, 12839–12844 (2011).
  Article PubMed PubMed Central Google Scholar
• Xue, X. et al. Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses. Nat. Struct. Mol. Biol. 24, 643–651 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, J. et al. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat. Immunol. 10, 728–733 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Papanastasiou, M. et al. Structural implications for the formation and function of the complement effector protein iC3b. J. Immunol. 198, 3326–3335 (2017).
  Article CAS PubMed Google Scholar
• van den Elsen, J.M. & Isenman, D.E. A crystal structure of the complex between human complement receptor 2 and its ligand C3d. Science 332, 608–611 (2011).
  Article CAS PubMed Google Scholar
• Xu, S., Wang, J., Wang, J.H. & Springer, T.A. Distinct recognition of complement iC3b by integrins αXβ2 and αMβ2. Proc. Natl. Acad. Sci. USA 114, 3403–3408 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Bajic, G., Yatime, L., Sim, R.B., Vorup-Jensen, T. & Andersen, G.R. Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3. Proc. Natl. Acad. Sci. USA 110, 16426–16431 (2013).
  Article PubMed PubMed Central Google Scholar